GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » Intangible Assets

Plandai Biotechnology (Plandai Biotechnology) Intangible Assets : $0.00 Mil (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Plandai Biotechnology's intangible assets for the quarter that ended in Jun. 2023 was $0.00 Mil.


Plandai Biotechnology Intangible Assets Historical Data

The historical data trend for Plandai Biotechnology's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology Intangible Assets Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Plandai Biotechnology Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Plandai Biotechnology  (OTCPK:PLPL) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Plandai Biotechnology Intangible Assets Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Plandai Biotechnology (Plandai Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
4811 49th Street, San Diego, CA, USA, 92115
Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.
Executives
Callum Baylis-duffield director FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula other: Former Director 175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson director P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield director, officer: President, Secretary and CFO 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield director 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki director 21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866

Plandai Biotechnology (Plandai Biotechnology) Headlines

From GuruFocus